Management of alkali burns : an 11-year retrospective review
- PMID: 11013181
- DOI: 10.1016/s0161-6420(00)00289-x
Management of alkali burns : an 11-year retrospective review
Abstract
Objective: To review the spectrum of patients with alkali burns admitted over an 11-year period and to assess the clinical outcomes after the introduction of a standard alkali burn treatment protocol.
Design: Retrospective nonrandomized comparative study.
Patients and interventions: A total of 121 patient records with alkali burns (n = 177 eyes) admitted to a tertiary hospital between 1987 and 1998 were reviewed. Eyes treated with a standard alkali burn treatment protocol, which included intensive topical steroids, ascorbate, citrate, and antibiotics, were compared with eyes treated by conservative management with antibiotics, and a short course of steroids.
Main outcome measures: Time to corneal reepithelialization, final best-corrected visual acuity, and time to visual recovery, length of hospital stay, and complications were analyzed.
Results: The standard protocol tended to delay corneal reepithelialization by one day (P: = not significant) in eyes with grade 1 burns (n = 76) and by 2 days (P: = 0.04) in grade 2 burns (n = 52), with no difference in final visual outcome. There were 37 eyes with grade 3 burns. Those treated with the standard protocol showed a trend toward more rapid corneal reepithelialization. Twenty-seven of 29 (93%) eyes with grade 3 injuries achieved a final best-corrected visual acuity of 20/40 or better compared with 3 of 6 (50%) eyes not treated according to the standard protocol (P: = 0.02). Eyes with grade 4 burns (n = 12), whether treated with the standard protocol or not, required 10 to 12 weeks for corneal reepithelialization. There was no statistically significant difference in final visual acuity.
Conclusions: On the basis of our findings, a number of recommendations can be made for the management of alkali injuries. Patients with a grade 1 or 2 injury do not require routine admission and do not benefit from the use of intensive treatment with ascorbate and citrate. A trend toward more rapid healing and a better final visual outcome were apparent in grade 3 burns, but our standard protocol made no difference in grade 4 burns.
Similar articles
-
Amniotic Membrane Transplantation in Acute Severe Ocular Chemical Injury: A Randomized Clinical Trial.Am J Ophthalmol. 2019 Mar;199:209-215. doi: 10.1016/j.ajo.2018.11.001. Epub 2018 Nov 10. Am J Ophthalmol. 2019. PMID: 30419194 Clinical Trial.
-
Evaluation of amniotic membrane transplantation as an adjunct to medical therapy as compared with medical therapy alone in acute ocular burns.Ophthalmology. 2005 Nov;112(11):1963-9. doi: 10.1016/j.ophtha.2005.05.022. Epub 2005 Sep 29. Ophthalmology. 2005. PMID: 16198422 Clinical Trial.
-
Topical steroid use in the treatment of ocular alkali burns.Br J Ophthalmol. 1997 Sep;81(9):732-4. doi: 10.1136/bjo.81.9.732. Br J Ophthalmol. 1997. PMID: 9422923 Free PMC article.
-
Alkali-related ocular burns: a case series and review.J Burn Care Res. 2014 May-Jun;35(3):261-8. doi: 10.1097/BCR.0b013e31829b0037. J Burn Care Res. 2014. PMID: 23877138 Review.
-
Ascorbate for alkali burns to the eye.Emerg Med J. 2003 Sep;20(5):465-6. doi: 10.1136/emj.20.5.465. Emerg Med J. 2003. PMID: 12954692 Free PMC article. Review.
Cited by
-
Proteomic analyses of corneal tissue subjected to alkali exposure.Invest Ophthalmol Vis Sci. 2011 Mar 1;52(3):1819-31. doi: 10.1167/iovs.10-5472. Invest Ophthalmol Vis Sci. 2011. PMID: 20861482 Free PMC article.
-
Topical Ascorbic Acid Ameliorates Oxidative Stress-Induced Corneal Endothelial Damage via Suppression of Apoptosis and Autophagic Flux Blockage.Cells. 2020 Apr 11;9(4):943. doi: 10.3390/cells9040943. Cells. 2020. PMID: 32290365 Free PMC article.
-
Trimebutine prevents corneal inflammation in a rat alkali burn model.Sci Rep. 2024 May 27;14(1):12111. doi: 10.1038/s41598-024-61112-4. Sci Rep. 2024. PMID: 38802470 Free PMC article.
-
Procollagen C-proteinase enhancer 1 (PCPE-1) functions as an anti-angiogenic factor and enhances epithelial recovery in injured cornea.Cell Tissue Res. 2017 Dec;370(3):461-476. doi: 10.1007/s00441-017-2689-6. Epub 2017 Sep 21. Cell Tissue Res. 2017. PMID: 28936615 Free PMC article.
-
Chemical eye injuries: a 10 year retrospective review of acute presentations and clinical outcomes in Auckland, New Zealand.Sci Rep. 2024 Apr 9;14(1):8264. doi: 10.1038/s41598-024-58670-y. Sci Rep. 2024. PMID: 38594410 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources